Legal Opinion
Mylan Pharmaceuticals, Inc. v. Proctor & Gamble Co.
District Court, S.D. New York
Decided February 21, 2006No. 03 Civ. 10150(PKC)PublishedCited by 7 opinions
1Opinion of the Court
MEMORANDUM AND ORDER
CASTEL, District Judge.
This is a Lanham Act action brought by Mylan Pharmaceuticals Inc. (“Mylan”) against The Procter & Gamble Company (“P & G”) asserting that P & G’s now-discontinued advertisements for Prilosec OTC were false or misleading. In 1989, the Food and Drug Administration (“FDA”) approved the sale of prescription omeprazole as a drug to treat, among other specifically identified conditions, gas-troesophageal reflux disease (“GERD”). Non-party Astra Zeneca PLC (“AZ”) marketed the product under the brand name “Prilosec”. With FDA approval, plaintiff Mylan now…
2Cases cited24 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Matsushita Electric Industrial Co., Ltd. v. Zenith Radio CorporationSupreme Court of the United States · 1986
- Richard Morales v. Quintel Entertainment, Inc. And Peter StolzCourt of Appeals for the Second Circuit · 2001
- Marie Powell v. National Board of Medical Examiners, University of Connecticut School of Medicine, Bruce M. KoeppenCourt of Appeals for the Second Circuit · 2004
- Pdk Labs, Inc., Plaintiff-Counter-Defendant-Appellee v. Mitchell K. Friedlander, Defendant-Counter-Claimant-AppellantCourt of Appeals for the Second Circuit · 1997
19 more not listed; retrieve them via the Exa API.
3Cited by7 opinions
- Apotex Inc. v. Acorda Therapeutics, Inc.Court of Appeals for the Second Circuit · 2016
- Enigma Software Group USA, LLC v. Bleeping Computer LLCDistrict Court, S.D. New York · 2016
- Merck Eprova AG v. Brookstone Pharmaceuticals, LLCDistrict Court, S.D. New York · 2013
- LuxSoma LLC v. Leg Res., Inc.District Court, S.D. Illinois · 2018
- Palin v. New York Times Co.District Court, S.D. New York · 2017
2 more not listed; retrieve them via the Exa API.